Company Filing History:
Years Active: 2023-2025
Title: Scott Leas: Innovator in Automated Insulin Delivery Systems
Introduction
Scott Leas is a prominent inventor based in San Diego, CA, known for his contributions to the field of diabetes therapy. He holds 2 patents that focus on improving automated insulin delivery systems. His work aims to enhance the quality of life for individuals managing diabetes through innovative technology.
Latest Patents
Leas's latest patents include systems and methods for automated insulin delivery for diabetes therapy. These patents disclose systems designed to mitigate the risk of insulin stacking in automated insulin delivery systems. In automated insulin delivery (AID) systems, insulin stacking can occur when the system automatically increases insulin delivery based on glucose levels, while the user also programs a meal bolus for carbohydrate intake. The systems and methods developed by Leas enable the AID system to account for recent automated insulin increases when a meal bolus is programmed, thereby reducing the risk of double dosing.
Career Highlights
Scott Leas is currently employed at Tandem Diabetes Care, Inc., where he continues to innovate in the field of diabetes management. His work is instrumental in developing technologies that provide better control and safety for diabetes patients.
Collaborations
Leas collaborates with notable colleagues such as Jacob Kearns and Michael Michaud, contributing to a team dedicated to advancing diabetes care through technology.
Conclusion
Scott Leas is a key figure in the development of automated insulin delivery systems, with a focus on enhancing patient safety and efficacy in diabetes therapy. His innovative patents and work at Tandem Diabetes Care, Inc. reflect his commitment to improving the lives of those living with diabetes.